Immune Defects in 28-kDa Proteasome Activator γ-Deficient Mice

Journal of Immunology

Volumn 172, Issue 6, 2004, Pages 3948-3954

  Barton, Lance F ^a   Runnels, Herbert A ^a   Schell, Todd D ^c   Cho, Yunjung ^d   Gibbons, Reta ^b   Tevethia, Satvir S ^c   Deepe Jr , George S ^b   Monaco, John J ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; PROTEASOME; PROTEASOME ACTIVATOR 28 KDA ALPHA; PROTEASOME ACTIVATOR 28 KDA GAMMA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME DEGRADATION; ENZYME SPECIFICITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LUNG INFECTION; MITOSIS; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 1542724417     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.6.3948     Document Type: Article

References (48)

1. Groettrup, M., S. Khan, K. Schwarz, and G. Schmidtke. 2001. Interferon-γ inducible exchanges of 20S proteasome active site subunits: why? Biochimie 83:367.
2. Goldberg, A. L., and K. L. Rock. 1992. Proteolysis, proteasomes and antigen presentation. Nature 357:375.
3. Monaco, J. J., and D. Nandi. 1995. The genetics of proteasomes and antigen processing. Annu. Rev. Genet. 29:729.
4. Lowe, J., D. Stock, B. Jap, P. Zwickl, W. Baumeister, and R. Huber. 1995. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3. 4 A resolution. Science 268:533.
5. Rechsteiner, M., C. Realini, and V. Ustrell. 2000. The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem. J. 345:1.
6. Unno, M., T. Mizushima, Y. Morimoto, Y. Tomisugi, K. Tanaka, N. Yasuoka, and T. Tsukihara. 2002. The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure 10:609.
7. Yao, Y., L. Huang, A. Krutchinsky, M. L. Wong, K. G. Standing, A. L. Burlingame, and C. C. Wang. 1999. Structural and functional characterizations of the proteasome-activating protein PA26 from Trypanosoma brucei. J. Biol. Chem. 274:33921.
8. Groll, M., L. Ditzel, J. Lowe, D. Stock, M. Bochtler, H. D. Bartunik, and R. Huber. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386:463.
9. Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801.
10. Dubiel, W., G. Pratt, K. Ferrell, and M. Rechsteiner. 1992. Purification of an 11 S regulator of the multicatalytic protease. J. Biol. Chem. 267:22369.
11. Ma, C. P., C. A. Slaughter, and G. N. DeMartino. 1992. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J. Biol. Chem. 267:10515.
12. Realini, C., W. Dubiel, G. Pratt, K. Ferrell, and M. Rechsteiner. 1994. Molecular cloning and expression of a γ-interferon-inducible activator of the multicatalytic protease. J. Biol. Chem. 269:20727.
13. Ahn, K., M. Erlander, D. Leturcq, P. A. Peterson, K. Fruh, and Y. Yang. 1996. In vivo characterization of the proteasome regulator PA28. J. Biol. Chem. 271:18237.
14. Soza, A., C. Knuehl, M. Groettrup, P. Henklein, K. Tanaka, and P. M. Kloetzel. 1997. Expression and subcellular localization of mouse 20S proteasome activator complex PA28. FEBS Lett. 413:27.
15. Wojcik, C., K. Tanaka, N. Paweletz, U. Naab, and S. Wilk. 1998. Proteasome activator (PA28) subunits, α, β and γ (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells. Eur. J. Cell Biol. 77:151.
16. Jiang, H., and J. J. Monaco. 1997. Sequence and expression of mouse proteasome activator PA28 and the related autoantigen Ki. Immunogenetics 46:93.
17. Fruh, K., and Y. Yang. 1999. Antigen presentation by MHC class I and its regulation by interferon γ. Curr. Opin. Immunol. 11:76.
18. Li, J., X. Gao, J. Ortega, T. Nazif, L. Joss, M. Bogyo, A. C. Steven, and M. Rechsteiner. 2001. Lysine 188 substitutions convert the pattern of proteasome activation by REGγ to that of REGs α and β. EMBO J. 20:3359.
19. Realini, C., C. C. Jensen, Z. Zhang, S. C. Johnston, J. R. Knowlton, C. P. Hill, and M. Rechsteiner. 1997. Characterization of recombinant REGα, REGβ, and REGγ proteasome activators. J. Biol. Chem. 272:25483.
20. Sun, Y., A. J. Sijts, M. Song, K. Janek, A. K. Nussbaum, S. Kral, M. Schirle, S. Stevanovic, A. Paschen, H. Schild, et al. 2002. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. Cancer Res. 62:2875.
21. Schwarz, K., M. Eggers, A. Soza, U. H. Koszinowski, P. M. Kloetzel, and M. Groettrup. 2000. The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition. Eur. J. Immunol. 30:3672.
22. Shimbara, N., H. Nakajima, N. Tanahashi, K. Ogawa, S. Niwa, A. Uenaka, E. Nakayama, and K. Tanaka. 1997. Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region. Genes Cells 2:785.
23. Murata, S., H. Kawahara, S. Tohma, K. Yamamoto, M. Kasahara, Y. Nabeshima, K. Tanaka, and T. Chiba. 1999. Growth retardation in mice lacking the proteasome activator PA28γ. J. Biol. Chem. 274:38211.
24. Loo, D. T., and C. W. Cotman. 1998. Primary and extended culture of embryonic mouse cells. In Cell Biology: A Laboratory Handbook, Vol. 1. J. E. Celis, ed. Academic Press, San Diego, p. 65.
25. Barton, L. F., M. Cruz, R. Rangwala, G. S. Deepe, Jr., and J. J. Monaco. 2002. Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection. J. Immunol. 169:3046.
26. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink, 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507.
27. Fu, T. M., L. M. Mylin, T. D. Schell, I. Bacik, G. Russ, J. W. Yewdell, J. R. Bennink, and S. S. Tevethia. 1998. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J. Virol. 72:1469.
28. Allendoerfer, R., G. P. Biovin, and G. S. Deepe, Jr. 1997. Modulation of immune responses in murine pulmonary histoplasmosis. J. Infect. Dis. 175:905.
29. Hess, K. L., J. D. Johnson, and J. M. Cook-Mills. 2001. Different orders for acquisition of apoptotic characteristics by leukocytes. J. Leukocyte Biol. 70:405.
30. Chen, W., L. C. Anton, J. R. Bennink, and J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12:83.
31. + T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J. Virol. 74:6922.
32. + T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol. 152:3491.
33. Zhang, Z., A. Clawson, C. Realini, C. C. Jensen, J. R. Knowlton, C. P. Hill, and M. Rechsteiner. 1998. Identification of an activation region in the proteasome activator REGα. Proc. Natl. Acad. Sci. USA 95:2807.
34. Li, J., and M. Rechsteiner. 2001. Molecular dissection of the 11S REG (PA28) proteasome activators. Biochimie 83:373.
35. Mylin, L. M., R. H. Bonneau, J. D. Lippolis, and S. S. Tevethia. 1995. Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69:6665.
36. Cain, J. A., and G. S. Deepe, Jr. 1998. Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. 66:1473.
37. Lloyd, R. V., L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer. 1999. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 154:313.
38. 1 cell cycle phase specific transcription factor in epithelial cells. Oncogene 21:1485.
39. Blaise, R., P. Masdehors, A. Lauge, D. Stoppa-Lyonnet, C. Alapetite, H. Merle-Beral, J. L. Binet, S. Omura, H. Magdelenat, L. Sabatier, et al. 2001. Chromosomal DNA and p53 stability, ubiquitin system and apoptosis in B-CLL lymphocytes. Leuk. Lymphoma 42:1173.
40. Naujokat, C., and S. Hoffmann. 2002. Role and function of the 26S proteasome in proliferation and apoptosis. Lab. Invest. 82:965.
41. Gregory, M. A., Q. Xiao, G. A. Cornwall, B. Lutterbach, and S. R. Hann. 2000. B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Oncogene 19:4886.
42. -/- mice. Science 286:2162.
43. Murata, S., H. Udono, N. Tanahashi, N. Hamada, K. Watanabe, K. Adachi, T. Yamano, K. Yui, N. Kobayashi, M. Kasahara, et al. 2001. Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β. EMBO J. 20:5898.
44. + T cells in host defense against Histoplasma capsulatum. Infect. Immun. 56:1685.
45. Allendorfer, R., G. D. Brunner, and G. S. Deepe, Jr. 1999. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J. Immunol. 162:7389.
46. Nandi, D., H. Jiang, and J. J. Monaco. 1996. Identification of MECL-1 (LMP-10) as the third IFN-γ-inducible proteasome subunit. J. Immunol. 156:2361.
47. Nandi, D., M. N. Iyer, and J. J. Monaco. 1996. Molecular and serological analysis of polymorphisms in the murine major histocompatibility complex-encoded proteasome subunits, LMP-2 and LMP-7. Exp. Clin. Immunogenet. 13:20.
48. Griffin, T. A., D. Nandi, M. Cruz, H. J. Fehling, L. V. Kaer, J. J. Monaco, and R. A. Colbert. 1998. Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN-γ)-inducible subunits. J. Exp. Med. 187:97.